The Centers for Medicare and Medicaid Services plans to clarify the types of drug line extensions that will be subject to inflation-based add-on rebates in Medicaid after considering further comments from stakeholders.
The agency deferred a final decision on a definition of line extensions in its recent final rule implementing changes to the Medicare drug rebate program under the Affordable Care Act....